SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Innoviva, Inc. (INVA) (CIK 0001080014) (INVA) — May 15, 2014

Innoviva, Inc. (INVA) (CIK 0001080014)
Date: May 15, 2014 · CIK: 0001080014 · Accession: 0000000000-14-024974

AI Filing Summary & Sentiment

File numbers found in text: 000-30319

Date
March 3, 2014
Author
/s/ Andrew Mew
Form
UPLOAD
Company
Innoviva, Inc. (INVA) (CIK 0001080014)

Letter

May 1 5, 2014 Via E -mail Michael W. Aguiar Chief Financial Officer Theravance, Inc. 901 Gateway Boulevard South San Francisco, California 94080

Re: Theravance, Inc. Form 10 -K for the Fiscal Year Ended December 31, 201 3 Filed March 3, 2014 File No. 000-30319

Dear Mr. Aguiar :

We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing include s the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Andrew Mew

Show Raw Text
May 1 5, 2014

Via E -mail
Michael W. Aguiar
Chief Financial  Officer
Theravance, Inc.
901 Gateway Boulevard
South San Francisco, California 94080

Re:  Theravance, Inc.
Form 10 -K for the Fiscal Year Ended December 31, 201 3
Filed March 3, 2014
File No. 000-30319

Dear Mr. Aguiar :

We have completed our review of your filing.  We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from taking
any action with respect to the company or the filing and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the United  States.  We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filing  to be certain that the filing include s the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

        /s/ Andrew Mew

Andrew Mew
        Accounting Branch Chief